CAUSES OF DEATH IN HIV-INFECTED PATIENTS IN A LARGE TUBERCULOSIS HOSPITAL OF KEMEROVO REGION
https://doi.org/10.22625/2072-6732-2017-9-3-25-31
Abstract
The aim was to study the causes of death in HIV patients in the Novokuznetsk tuberculosis dispensary in 2016 (population is 550 thousand people; about 2% of population are HIV-positive).
Materials and methods: Protocols of all autopsies of HIV-infected patients (n=221) performed in 2016 in the Novokuznetsk tuberculosis dispensary.
Results: The mean age of the deceased was 37Ѓ}6,9 years. HIV and tuberculosis (TB) co-infection was in 83,3% of patients (n=184), HIV/TB and other opportunistic or severe somatic diseases – in 10,4% (n=23), non-tuberculous opportunistic diseases – in 6,3% (n=14). The new tuberculosis cases were in 71,1% (n=147), relapses – in 7,2% (n=15), chronic tuberculosis cases – in 21,7% of patients (n=45). Disseminated form prevailed among the cases of respiratory tuberculosis; generalized tuberculosis (3 and more localizations) occurred in 87,0% (n=180), tuberculosis meningitis was found in 17,9% (n=37). Positive fluorescent sputum microscopy was in 72.5%, sputum cultures on Loewenstein-Jensen medium – in 78,3% with HIV/TB. Primary multidrug resistance was detected in 60,7% (including in 5,8% of them with primary extensively drug resistance). Severe opportunistic infections or malignancies were in 9,2% of HIV/TB (n=19) and in 78,7% of non-TB patients (n=11). Data on the CD4 level was known in 68,8% of cases (n=152): the median count was 75,5 cells/μl; 38,9% of new TB cases (n=46) were diagnosed with HIV in time of TB detecting. Antiretroviral therapy was performed only 13% of patients (n=29).
Conclusion: There is a need for the optimization of HIV detecting approaches and early initiation of antiretroviral therapy before the appearance of incurable opportunistic diseases, as well as for comprehensive TB prevention.
About the Authors
I. B. ViktororvaRussian Federation
Novokuznetsk
A. L. Khanin
Russian Federation
Novokuznetsk
V. N. Zimina
Russian Federation
Moscow
References
1. Nechaeva O.B. Jepidemicheskaja situacija po tuberkulezu sredi lic s VICh-infekciej v Rossijskoj Federacii //Tuberkuljoz i bolezni ljogkih. – 2017. – №3. – C. 13-19.
2. Federal’nye klinicheskie rekomendacii po organizacii i provedeniju mikrobiologicheskoj i molekuljarno-geneticheskoj diagnostiki uberkuleza http://roftb.ru/netcat_files/doks2015/rec8.pdf
3. Campos L.C., Rocha M. V. V., Willers D. M. C. et al. Characteristics of Patients with Smear-Negative Pulmonary Tuberculosis (TB) in a Region with High TB and HIV Prevalence // PLOS ONE. 2016. 11(1): e0147933
4. Uthman O.A., Okwundu С., Gbenga K. et al. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. //Ann Intern Med. 2015. 163(1):32-9.
5. Yan S., Chen L., Wu W. et al. Early versus Delayed Antiretroviral Therapy for HIV and Tuberculosis Co-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials//PLoS ONE. 2015. 10(5): e0127645.
Review
For citations:
Viktororva I.B., Khanin A.L., Zimina V.N. CAUSES OF DEATH IN HIV-INFECTED PATIENTS IN A LARGE TUBERCULOSIS HOSPITAL OF KEMEROVO REGION. Journal Infectology. 2017;9(3):25-31. (In Russ.) https://doi.org/10.22625/2072-6732-2017-9-3-25-31